- Home
- SAMO vs SRZN Comparison
SAMO vs SRZN Comparison
Compare SAMO & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$25.83
Company Overview
Basic Information| Metric | SAMO | SRZN |
|---|---|---|
| Founded | 2026 | 2015 |
| Country | United States | United States |
| Employees | N/A | 59 |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.8M | 276.3M |
| IPO Year | 2026 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SAMO | SRZN |
|---|---|---|
| Price | $9.80 | $25.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $48.40 |
| AVG Volume (30 Days) | 79.2K | ★ 943.6K |
| Earning Date | N/A | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,477,000.00 |
| Revenue This Year | N/A | $208.89 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.80 | $11.39 |
| 52 Week High | $9.85 | $37.83 |
Technical Indicators
Market Signals| Indicator | SAMO | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 41.67 | 52.22 |
| Support Level | $9.80 | $23.31 |
| Resistance Level | $9.83 | $28.78 |
| Average True Range (ATR) | 0.01 | 2.74 |
| MACD | -0.00 | -0.34 |
| Stochastic Oscillator | 14.29 | 43.37 |
Price Performance
Historical Comparison SAMO
SRZN
About SAMO Samos Energy Acquisition Corporation Class A Ordinary Shares
Samos Energy Acquisition Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).